Physician

Long Henry Pham, M.D.

According to 2025 Medicare claims, Long Pham, M.D. (NPI: 1366553380) practices gastroenterology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is CENTRAL TEXAS DIGESTIVE DISEASE ASSOCIATION, PA (NPI: 1639260763; TIN: 742752549) and primary practice location at 77845-8306. Pham is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542), CHI Saint Joseph Health Partners (ACO ID: A4638), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Pham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 4,110 HCPCS/CPT codes, and received $157,952 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,613 prescription claims across 690 beneficiaries totaling $1,261,569 in drug costs, led by Gattex (Teduglutide). Open Payments data shows 20 records totaling $592. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $834,755 to $1,261,569. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,022	2,574	$218,670
2016	1,056	2,648	$206,433
2017	461	1,126	$63,523
2018	619	1,208	$121,960
2019	714	1,619	$134,246
2020	634	1,593	$125,324
2021	653	1,397	$122,641
2022	711	2,484	$145,209
2023	687	1,860	$139,226
2024	549	4,110	$157,952

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	414	1,358	$834,755
2016	449	1,463	$653,382
2017	247	855	$345,197
2018	358	1,097	$287,564
2019	498	1,413	$621,408
2020	532	1,573	$1,096,632
2021	515	1,447	$1,171,210
2022	549	1,513	$1,375,695
2023	574	1,483	$1,220,672
2024	690	1,613	$1,261,569

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	170	170	$199
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	134	171	$87
43235	Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope	75	77	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	76	85	$61
88305	Pathology examination of tissue using a microscope, intermediate complexity	179	292	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gattex	Teduglutide	11	330	$500,295
Humira(Cf) Pen	Adalimumab	11	756	$290,003
Mesalamine	Mesalamine	39	3,300	$48,210
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	343	418	$21,934
Creon	Lipase/Protease/Amylase	12	449	$19,688

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$592	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Long Henry Pham, M.D.?

Tedicare shows public-source Medicare data for Long Henry Pham, M.D. (NPI 1366553380), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Long Henry Pham, M.D. have ACO affiliation data?

Long Henry Pham, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542), CHI Saint Joseph Health Partners (MSSP, ACO ID A4638), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Long Henry Pham, M.D.?

Long Henry Pham, M.D. is linked to CENTRAL TEXAS DIGESTIVE DISEASE ASSOCIATION, PA (billing NPI 1639260763) in the available physician profile data.

Does Long Henry Pham, M.D. have Open Payments data?

Long Henry Pham, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.